News and Stocks Pulse

Stocks › PRVA

Privia Health Group, Inc. (PRVA) stock analysis

SKIP 9% confidence · analysed Nov 2, 2026

On Nov 2, 2026, our model rated Privia Health Group, Inc. (PRVA) SKIP with 9% confidence at a price of $21.08. That means the signals cancel out; the model sees no clear edge either way.

Analysed price$21.08

Technical picture

The 14-day RSI is 44. Momentum is soft: below the neutral 50 line, but not yet oversold.

MACD is below its signal line, so short-term momentum is pointing down.

The price is above its 50-day moving average but still below the 200-day: a short-term recovery inside a longer-term downtrend.

Volume is only 0.4x its 20-day average; light trading makes the latest move less convincing.

Trend structure and money flow

Market structure: ranging / no clear structure.

The most recent swing high is $28.82 and the swing low is $19.53; traders often treat these as resistance and support.

Fundamentals

The company reports a profit margin of 1.2% and revenue growth of +21.4%.

In its latest quarter it earned $0.19 per share, which missed the $0.24 analysts expected, with revenue +21.4% year over year.

Wall Street's average rating is 1.4 on a 1 (strong buy) to 5 (sell) scale, roughly a "strong buy", with an average price target of $31.47.

The next earnings report is expected around Nov 5, 2026; prices often move sharply around earnings.

The model's one-paragraph read

No clear edge (SKIP) — composite score +0.09 (SKIP). Technicals: RSI 43.87, MACD bearish, price above SMA50. Fundamentals: margin 1.2%, revenue growth 21.4%. Financial results: YoY revenue +21.4%, last EPS surprise -20.8%, next earnings 2026-11-05. Smart Money Concepts: ranging / no clear structure. FinGPT news read: positive. Reference price $21.1; no trade levels (SKIP).

Past ratings for PRVA

DateVerdictConfidencePriceMove since
Nov 2, 2026SKIP9%$21.08—

"Move since" compares each call's price with the latest analysed price.

Recent news on PRVA

Nov 2, 2026 · Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business

FinBERT, a financial-language model, scores this headline as positive (92% confidence). That is the news tone only — not the full stock rating.

Search all news on PRVA →

Frequently asked questions

Is PRVA a buy right now?

As of Nov 2, 2026, our automated model rates Privia Health Group, Inc. (PRVA) SKIP with 9% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.

When does Privia Health Group, Inc. report earnings next?

The next earnings report is expected around Nov 5, 2026.

What does a SKIP rating mean?

A SKIP rating means the signals cancel out; the model sees no clear edge either way.

For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.